Locations

Amsterdam, Netherlands

Size

51 - 200 employees

Stage

Series A

founded in

2020

VectorY is a fully integrated gene therapy company specializing in the development of novel therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a particular emphasis on muscle diseases. It combines the therapeutic potential of antibodies and gene therapy to create long-term therapeutic solutions for large disease areas with significant unmet medical need. VectorY was founded in the Amsterdam Science Park in August 2020.

Something looks off?
Open jobs at VectorY

On-site & Remote